Human Chorionic Gonadotropin (HCG) hormone is secreted by the placenta. The HCG hormone is a type of hormone which is released after it is being implanted by a fertilized zygote within the uterus. This hormone plays vital role in stimulation of the egg that is released from the ovary and helps in the growth of the egg. In case of treatment in infertilities, women ovulation and male sperm counts are induced by HCG. The trophoblast tissue produces this human chorionic gonadotropin hormone found in the embryos.
The market for HCG across the world is predicted to be priced at US$ 710.88 Mn in the year 2022 and is anticipated to show a CAGR of 6.5% in the projected period of 2022-2030.
To Get More Business Strategies Sample Copy of Report @ https://www.coherentmarketinsights.com/insight/request-sample/1011
The rise in the rate of infertility worldwide is anticipated to increase development of the market of human chorionic gonadotropin (HCG) globally in the predicted period.
Globally, the rise in the rates of infertility is anticipated to increase development and expansion of the market of HCG or human chorionic gonadotropin across the world in the predicted period. For example, as per the reports published in 2018, in Galadari Printing and Publishing LLC, the occurrence of infertility has amplified with a major fall in the demographics extending from 6.6 births every woman in 1970s to 5.22 births in 1980-1985 and to 1.73 births every woman from 2015-2020 with an overall reduction of 160%.
The rise in the occurrence of the disorders in relation to hypogonadism is anticipated to boost the growth of the market in the estimated period.
The rise in the occurrence of the disorders in relation to hypogonadism is anticipated to boost the growth of the market in the estimated period. For example, in January 2022, as per the Endocrine Society, hypogonadism has become a familiar state in the population of the male with high occurrence in the older men, men with obesity and men suffering from type 2 diabetes.
Global Human Chorionic Gonadotropin (HCG) Market – Impact of Coronavirus (COVID-19) Pandemic_PR
The health industry was very badly affected due to the lockdown owing to the coronavirus pandemic. All the healthcare facilities got interrupted disrupted and were also affected due to the COVID-19 lockdown. The supply chain system and the distribution network of countries like Spain, India, Italy, U.K., and the U.S got disturbed owing to the lockdown guidelines laid down by the government. On other hand, countries like, the U.A.E., Saudi Arabia, Egypt and others confronted obstacles regarding transportation of chemical, raw materials and finished products. The COVID-1 Pandemic had its first outbreak in Wuhan, China which later spread to continents, causing widespread damage to industries across the globe. Supply of the important materials was interrupted owing to reasons of quarantine and deficit of labor supply. The conection between the warehouses were not smooth enough for easy transportation of the raw material needed for the expansion of the product amongst the region
Inquire More Or Share Questions If Any Before The Purchase On This Report @ https://www.coherentmarketinsights.com/insight/talk-to-analyst/1011
Global Human Chorionic Gonadotropin (HCG) Market: Restraint_PR
The causes which hindered the market growth of human chorionic gonadotropin (HCG) are the aftereffects related with HCG, like pain in the chest, very fast gaining weight, troubled breathing, nausea, vomiting, infrequent urination, pain in leg or swelled up legs, one sided body numbness. Moreover, alternatives being easily available in treatment of infertility, obstructs the growth of the market.
Key Players_PR
The main companies operating in the market of human chorionic gonadotropin (HCG) across the globe include Merck & Co., Inc., Ferring B.V.,Fresenius SE & Co.KGaA, Lupin, Sun Pharmaceutical Industries Ltd,Lee BioSolutions,Serum Institute of India Pvt. Ltd., Scripps Laboratories,Sanzyme Biologics Pvt. Ltd.,VHB Medi Sciences Limited Bharat Serums And Vaccines Limited (BSV), Zydus Lifesciences Ltd, Corona Remedies Pvt. Ltd
Purchase This Premium Report @ https://www.coherentmarketinsights.com/insight/buy-now/1011
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Therapeutics Application
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunity
- Impact Analysis
- Opportunities
- Impact Analysis
- Market Trends
- Key Highlights
- HCG Dosage Form Variation
- Supply Chain Analysis
- PEST Analysis
- Overview- Major HCG Therapeutic Areas
- Major Brand Analysis and Pricing Analysis
- Off-label Usage of HCG for Chronic Pain (US$ Mn) By Country (2017-2030)
- Market Dynamics
- Global Human Chorionic Gonadotropin (HCG) Market– Impact of Coronavirus (COVID-19) Pandemic
- Economic Impact
- Impact on Demand and Supply
- COVID-19 Impact Assessments
- Global Human Chorionic Gonadotropin (HCG) Market, By Product Type, 2017-2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 – 2030
- Segment Trends
- Human Chorionic Gonadotropin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
- Human Recombinant Human Chorionic Gonadotropin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
- Introduction
- Global Human Chorionic Gonadotropin (HCG) Market, By Therapeutic Application , 2017-2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 – 2030
- Segment Trends
- Male Hypogonadism
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
- Female Infertility Treatment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
- Oligospermic Treatment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
- Chronic Pain
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
- Cryptorchidism Treatment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
- Introduction
- Global Human Chorionic Gonadotropin (HCG) Market, By Distribution Channel, 2017-2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 – 2030
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
- Introduction
About Us:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact Us:
Mr. Shah
Coherent Market Insights Pvt Ltd,
533 Airport Boulevard, Suite 400, Burlingame, CA 94010, United States
Email: sales@coherentmarketinsights.com
Phone: U.S.: +1-206-701-6702
U.K.: +44-020-8133-4027
JAPAN: +81-50-5539-1737
INDIA: +91-848-285-0837